Working… Menu

Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome (VAMOS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00891267
Recruitment Status : Completed
First Posted : May 1, 2009
Last Update Posted : December 24, 2018
Information provided by:
Daiichi Sankyo, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2011
Actual Study Completion Date : May 2011